CN105142612A - 用于直肠给药的药物组合物 - Google Patents

用于直肠给药的药物组合物 Download PDF

Info

Publication number
CN105142612A
CN105142612A CN201480012934.5A CN201480012934A CN105142612A CN 105142612 A CN105142612 A CN 105142612A CN 201480012934 A CN201480012934 A CN 201480012934A CN 105142612 A CN105142612 A CN 105142612A
Authority
CN
China
Prior art keywords
pharmaceutical composition
foam
compositions
agent
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480012934.5A
Other languages
English (en)
Chinese (zh)
Inventor
S·M·普伦戴尔
G·马尔霍特拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of CN105142612A publication Critical patent/CN105142612A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CN201480012934.5A 2013-03-08 2014-03-07 用于直肠给药的药物组合物 Pending CN105142612A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN711/MUM/2013 2013-03-08
PCT/GB2014/050678 WO2014135891A1 (en) 2013-03-08 2014-03-07 Pharmaceutical compositions for rectal administration
IN711MU2013 IN2013MU00711A (enExample) 2013-03-08 2014-03-07

Publications (1)

Publication Number Publication Date
CN105142612A true CN105142612A (zh) 2015-12-09

Family

ID=50382472

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480012934.5A Pending CN105142612A (zh) 2013-03-08 2014-03-07 用于直肠给药的药物组合物

Country Status (12)

Country Link
US (1) US20160002278A1 (enExample)
EP (1) EP2964196A1 (enExample)
JP (1) JP2016511268A (enExample)
CN (1) CN105142612A (enExample)
AU (1) AU2014224397A1 (enExample)
BR (1) BR112015021501A2 (enExample)
CA (1) CA2902852A1 (enExample)
IN (1) IN2013MU00711A (enExample)
MX (1) MX2015011894A (enExample)
RU (1) RU2015140498A (enExample)
WO (1) WO2014135891A1 (enExample)
ZA (1) ZA201401683B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109394694A (zh) * 2018-09-30 2019-03-01 北京兴源联合医药科技有限公司 一种无水泡沫剂

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104546672B (zh) * 2014-12-19 2017-12-22 华北制药集团新药研究开发有限责任公司 一种非达霉素肠溶制剂
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
RU2646495C2 (ru) * 2015-12-28 2018-03-05 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Фармацевтические композиции в форме ректальных суппозиториев, содержащие нефопама гидрохлорид (варианты), их применение для лечения острого и хронического болевого синдрома и способы получения
WO2018009789A1 (en) * 2016-07-08 2018-01-11 Vanderbilt University Treatment and prevention of clostridium difficile colitis using misoprostol
RU2661618C1 (ru) * 2017-11-23 2018-07-17 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Суппозитории нефопама для лечения острого и хронического болевого синдрома на липофильной основе и способ их получения
RU2661617C1 (ru) * 2017-11-23 2018-07-17 Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" Суппозитории нефопама для лечения острого и хронического болевого синдрома на гидрофильной эмульсионной основе и способ их получения
JP2021524505A (ja) * 2018-05-19 2021-09-13 ゲイリー ビンヤミン， 発泡体製剤および身体への送達法
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法
CA3216267A1 (en) * 2021-04-22 2022-10-27 Glenn W. Laub Foam compositions for treating clostridioides difficile infections

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225096A (zh) * 1996-07-12 1999-08-04 艾博特公司 溴代台勾霉素化合物
CN1713891A (zh) * 2002-10-25 2005-12-28 弗米克斯有限公司 化妆品与药物泡沫
CN1856294A (zh) * 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
US20060269485A1 (en) * 2002-11-29 2006-11-30 Foamix Ltd. Antibiotic kit and composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2011146621A2 (en) * 2010-05-18 2011-11-24 Optimer Pharmaceuticals, Inc. Treatment of clostridium difficile infection in patients undergoing antibiotic therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US6969520B2 (en) 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
GB0921288D0 (en) 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection
US20130022575A1 (en) 2011-07-19 2013-01-24 Microbial Rx Systems and methods of replacing intestinal flora

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225096A (zh) * 1996-07-12 1999-08-04 艾博特公司 溴代台勾霉素化合物
CN1713891A (zh) * 2002-10-25 2005-12-28 弗米克斯有限公司 化妆品与药物泡沫
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20060269485A1 (en) * 2002-11-29 2006-11-30 Foamix Ltd. Antibiotic kit and composition and uses thereof
CN1856294A (zh) * 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
WO2011146621A2 (en) * 2010-05-18 2011-11-24 Optimer Pharmaceuticals, Inc. Treatment of clostridium difficile infection in patients undergoing antibiotic therapy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109394694A (zh) * 2018-09-30 2019-03-01 北京兴源联合医药科技有限公司 一种无水泡沫剂

Also Published As

Publication number Publication date
US20160002278A1 (en) 2016-01-07
MX2015011894A (es) 2015-12-15
WO2014135891A1 (en) 2014-09-12
CA2902852A1 (en) 2014-09-12
RU2015140498A (ru) 2017-04-13
BR112015021501A2 (pt) 2017-07-18
IN2013MU00711A (enExample) 2015-06-26
AU2014224397A1 (en) 2015-09-10
JP2016511268A (ja) 2016-04-14
EP2964196A1 (en) 2016-01-13
ZA201401683B (en) 2017-06-28

Similar Documents

Publication Publication Date Title
CN105142612A (zh) 用于直肠给药的药物组合物
CN102724960A (zh) 局部泡沫组合物
ES2314408T3 (es) Formulaciones de hfc en solucion que contienen un anticolinergico.
JP2023022177A (ja) 治療用アプレミラスト局所組成物
CN102724961A (zh) 局部泡沫组合物
CN104519867A (zh) 药物组合物
CN102325522A (zh) 基本不含药物活性成分的可发泡组合物用于治疗人体皮肤的用途
MX2009002311A (es) Composiciones farmaceuticas para tratamiento de infecciones fungales.
CN107249595A (zh) 灌肠剂
US20150196488A1 (en) Topical Foam Composition
JP2007291073A (ja) 痔疾用噴霧製剤
KR20150136081A (ko) 직장 투여용 약학 조성물
JP2009286710A (ja) ゲル軟膏組成物
CN120712072A (zh) 含有janus激酶抑制剂的外用组合物
KR20180128450A (ko) 글리코피롤레이트의 국소 스프레이 포뮬레이션
EP1810666A1 (en) Foam-Forming composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151209